866-997-4948(US-Canada Toll Free)

United States Genome Editing/Genome Engineering Market Report 2016

Published By :

QYResearch

Published Date : Oct 2016

Category :

Biotechnology

No. of Pages : 118 Pages

Notes:
Sales, means the sales volume of Genome Editing/Genome Engineering
Revenue, means the sales value of Genome Editing/Genome Engineering

This report studies sales (consumption) of Genome Editing/Genome Engineering in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Thermo Fisher Scientific, Inc. (U.S.)
Merck KGAA (Germany)
Horizon Discovery Group Plc (U.K.)
Genscript Biotech Corporation (U.S.)
Sangamo Biosciences, Inc. (U.S.)
Integrated DNA Technologies, Inc (U.S.)
Lonza Group Ltd. (Switzerland)
New England Biolabs, Inc. (U.S.)
Origene Technologies, Inc. (U.S.)
Transposagen Biopharmaceuticals, Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
CRISPR
TALEN
ZFN
Antisense
Other Technologies
Split by applications, this report focuses on sales, market share and growth rate of Genome Editing/Genome Engineering in each application, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other Applications
 

Table of Contents

United States Genome Editing/Genome Engineering Market Report 2016
1 Genome Editing/Genome Engineering Overview
1.1 Product Overview and Scope of Genome Editing/Genome Engineering
1.2 Classification of Genome Editing/Genome Engineering
1.2.1 CRISPR
1.2.2 TALEN
1.2.3 ZFN
1.2.4 Antisense
1.2.5 Other Technologies
1.3 Application of Genome Editing/Genome Engineering
1.3.1 Cell Line Engineering
1.3.2 Animal Genetic Engineering
1.3.3 Plant Genetic Engineering
1.3.4 Other Applications
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Genome Editing/Genome Engineering (2011-2021)
1.4.1 United States Genome Editing/Genome Engineering Sales and Growth Rate (2011-2021)
1.4.2 United States Genome Editing/Genome Engineering Revenue and Growth Rate (2011-2021)

2 United States Genome Editing/Genome Engineering Competition by Manufacturers
2.1 United States Genome Editing/Genome Engineering Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Genome Editing/Genome Engineering Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Genome Editing/Genome Engineering Average Price by Manufactures (2015 and 2016)
2.4 Genome Editing/Genome Engineering Market Competitive Situation and Trends
2.4.1 Genome Editing/Genome Engineering Market Concentration Rate
2.4.2 Genome Editing/Genome Engineering Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Genome Editing/Genome Engineering Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Genome Editing/Genome Engineering Sales and Market Share by Type (2011-2016)
3.2 United States Genome Editing/Genome Engineering Revenue and Market Share by Type (2011-2016)
3.3 United States Genome Editing/Genome Engineering Price by Type (2011-2016)
3.4 United States Genome Editing/Genome Engineering Sales Growth Rate by Type (2011-2016)

4 United States Genome Editing/Genome Engineering Sales (Volume) by Application (2011-2016)
4.1 United States Genome Editing/Genome Engineering Sales and Market Share by Application (2011-2016)
4.2 United States Genome Editing/Genome Engineering Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Genome Editing/Genome Engineering Manufacturers Profiles/Analysis
5.1 Thermo Fisher Scientific, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck KGAA (Germany)
5.2.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck KGAA (Germany) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Horizon Discovery Group Plc (U.K.)
5.3.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Genscript Biotech Corporation (U.S.)
5.4.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sangamo Biosciences, Inc. (U.S.)
5.5.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Integrated DNA Technologies, Inc (U.S.)
5.6.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lonza Group Ltd. (Switzerland)
5.7.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 New England Biolabs, Inc. (U.S.)
5.8.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Origene Technologies, Inc. (U.S.)
5.9.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Transposagen Biopharmaceuticals, Inc. (U.S.)
5.10.2 Genome Editing/Genome Engineering Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 Genome Editing/Genome Engineering Manufacturing Cost Analysis
6.1 Genome Editing/Genome Engineering Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Genome Editing/Genome Engineering

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Genome Editing/Genome Engineering Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Genome Editing/Genome Engineering Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Genome Editing/Genome Engineering Market Forecast (2016-2021)
10.1 United States Genome Editing/Genome Engineering Sales, Revenue Forecast (2016-2021)
10.2 United States Genome Editing/Genome Engineering Sales Forecast by Type (2016-2021)
10.3 United States Genome Editing/Genome Engineering Sales Forecast by Application (2016-2021)
10.4 Genome Editing/Genome Engineering Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
 

List of Table

List of Tables and Figures

Figure Picture of Genome Editing/Genome Engineering
Table Classification of Genome Editing/Genome Engineering
Figure United States Sales Market Share of Genome Editing/Genome Engineering by Type in 2015
Figure CRISPR Picture
Figure TALEN Picture
Figure ZFN Picture
Figure Antisense Picture
Figure Other Technologies Picture
Table Application of Genome Editing/Genome Engineering
Figure United States Sales Market Share of Genome Editing/Genome Engineering by Application in 2015
Figure Cell Line Engineering Examples
Figure Animal Genetic Engineering Examples
Figure Plant Genetic Engineering Examples
Figure Other Applications Examples
Figure United States Genome Editing/Genome Engineering Sales and Growth Rate (2011-2021)
Figure United States Genome Editing/Genome Engineering Revenue and Growth Rate (2011-2021)
Table United States Genome Editing/Genome Engineering Sales of Key Manufacturers (2015 and 2016)
Table United States Genome Editing/Genome Engineering Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genome Editing/Genome Engineering Sales Share by Manufacturers
Figure 2016 Genome Editing/Genome Engineering Sales Share by Manufacturers
Table United States Genome Editing/Genome Engineering Revenue by Manufacturers (2015 and 2016)
Table United States Genome Editing/Genome Engineering Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genome Editing/Genome Engineering Revenue Share by Manufacturers
Table 2016 United States Genome Editing/Genome Engineering Revenue Share by Manufacturers
Table United States Market Genome Editing/Genome Engineering Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genome Editing/Genome Engineering Average Price of Key Manufacturers in 2015
Figure Genome Editing/Genome Engineering Market Share of Top 3 Manufacturers
Figure Genome Editing/Genome Engineering Market Share of Top 5 Manufacturers
Table United States Genome Editing/Genome Engineering Sales by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Sales Share by Type (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Market Share by Type in 2015
Table United States Genome Editing/Genome Engineering Revenue and Market Share by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Genome Editing/Genome Engineering by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Price by Type (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Growth Rate by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Sales by Application (2011-2016)
Table United States Genome Editing/Genome Engineering Sales Market Share by Application (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Market Share by Application in 2015
Table United States Genome Editing/Genome Engineering Sales Growth Rate by Application (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Merck KGAA (Germany) Basic Information List
Table Merck KGAA (Germany) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGAA (Germany) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Horizon Discovery Group Plc (U.K.) Basic Information List
Table Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Genscript Biotech Corporation (U.S.) Basic Information List
Table Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Sangamo Biosciences, Inc. (U.S.) Basic Information List
Table Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Integrated DNA Technologies, Inc (U.S.) Basic Information List
Table Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Lonza Group Ltd. (Switzerland) Basic Information List
Table Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Origene Technologies, Inc. (U.S.) Basic Information List
Table Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Basic Information List
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genome Editing/Genome Engineering
Figure Manufacturing Process Analysis of Genome Editing/Genome Engineering
Figure Genome Editing/Genome Engineering Industrial Chain Analysis
Table Raw Materials Sources of Genome Editing/Genome Engineering Major Manufacturers in 2015
Table Major Buyers of Genome Editing/Genome Engineering
Table Distributors/Traders List
Figure United States Genome Editing/Genome Engineering Production and Growth Rate Forecast (2016-2021)
Figure United States Genome Editing/Genome Engineering Revenue and Growth Rate Forecast (2016-2021)
Table United States Genome Editing/Genome Engineering Production Forecast by Type (2016-2021)
Table United States Genome Editing/Genome Engineering Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *